Arcus Biosciences Inc (RCUS)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -282,000 | -269,000 | -246,000 | -227,000 | -301,000 | -288,000 | -284,000 | -277,000 | -266,000 | 82,538 | 69,563 | 60,593 | 55,000 | -278,391 | -198,594 | -167,698 | -122,858 | -87,603 | -111,777 | -94,793 |
| Revenue (ttm) | US$ in thousands | 258,000 | 263,000 | 247,000 | 237,000 | 117,000 | 119,355 | 121,236 | 118,995 | 112,000 | 433,144 | 408,724 | 399,137 | 398,304 | 53,292 | 108,361 | 92,939 | 77,517 | 77,780 | 15,000 | 15,000 |
| Pretax margin | -109.30% | -102.28% | -99.60% | -95.78% | -257.26% | -241.30% | -234.25% | -232.78% | -237.50% | 19.06% | 17.02% | 15.18% | 13.81% | -522.39% | -183.27% | -180.44% | -158.49% | -112.63% | -745.18% | -631.95% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-282,000K ÷ $258,000K
= -109.30%
The pretax margin of Arcus Biosciences Inc shows a fluctuating trend over the specified period, starting from extremely negative values in 2020 and gradually improving to positive values in 2021 and 2022. However, the margin dips back into negative territory in 2023 and 2024. This erratic pattern indicates volatility in the company's ability to generate profits before taxes relative to its revenue during these periods. Further analysis of the underlying financial performance and cost structures would be necessary to understand the factors driving these fluctuations and to assess the company's overall financial health and profitability over time.
Peer comparison
Dec 31, 2024